Showing results (571-580 of 10,439) with videos related to
Sort By:
Pageof 1,044
AIDS (London, England)|August 14, 2018
Is HIV patient navigation associated with HIV care continuum outcomes?Yuko Mizuno, Darrel H Higa, Carolyn A Leighton, et al.AIDS (London, England)|May 26, 2018
Per-partner condom effectiveness against HIV for men who have sex with menWayne D Johnson, Ann O'Leary, Stephen A FloresAIDS (London, England)|May 26, 2018
Coformulated bictegravir, emtricitabine, tenofovir alafenamide after initial treatment with bictegravir or dolutegravir and emtricitabine/tenofovir alafenamidePaul E Sax, Edwin DeJesus, Gordon Crofoot, et al.AIDS (London, England)|April 24, 2018
Psychoactive substances, alcohol and tobacco consumption in HIV-infected outpatientsJean-Marc Jacquet, Hélène Peyriere, Alain Makinson, et al.AIDS (London, England)|April 24, 2018
Temporal stability of HIV prevalence in high-burden areas regardless of declines in national HIV prevalence in Malawi and ZimbabweDiego F Cuadros, Adam J Branscum, Zindoga MukandavireAIDS (London, England)|April 24, 2018
Detection of numerous HIV-1/MO recombinants in FranceFabienne De Oliveira, Pierre Cappy, Véronique Lemée, et al.AIDS (London, England)|April 24, 2018
HIV transmission from infected CD4+ T cells to allogenic T and dendritic cells is inhibited by broadly neutralizing antibodiesCamille Ducloy, Bin Su, Luzia Mayr, et al.AIDS (London, England)|October 10, 2021
Results of a cluster randomized trial testing the systems analysis and improvement approach to increase HIV testing in family planning clinicsMcKenna C Eastment, George Wanje, Barbra A Richardson, et al.AIDS (London, England)|October 10, 2021
HIV-associated wasting prevalence in the era of modern antiretroviral therapyJaveed Siddiqui, Shanti K Samuel, Brooke Hayward, et al.AIDS (London, England)|October 10, 2021
HIV-1 drug resistance and genetic diversity in a cohort of people with HIV-1 in NigeriaPaul E Oluniyi, Fehintola V Ajogbasile, Shuntai Zhou, et al.Pageof 1,044